Trials / Completed
CompletedNCT06695377
Thromboembolic Complications in Mild Covid-19 Cases
Thromboembolic Complications Post-COVID-19: What is the Risk in Mild-Moderate Cases?
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 961 (actual)
- Sponsor
- Marmara University Pendik Training and Research Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to investigate the frequency of thromboembolic complications and the factors influencing them in COVID-19 cases that did not require hospitalization. For this purpose, patients registered at two different family health centers in Istanbul were retrospectively screened, and their status regarding post-COVID-19 thromboembolic events was recorded. The sociodemographic characteristics, medical history, COVID-19 treatments received, comorbidities, and current medications of all patients were examined and compared with the occurrence of complications.
Detailed description
Studies on COVID-19 complications in the literature have predominantly focused on patients treated in hospitals, particularly in intensive care units. Data on patients with mild to moderate symptoms who were followed up on an outpatient basis in primary care are quite limited. Therefore, our research investigated the incidence of thrombotic events within six months following infection in mild to moderate COVID-19 cases and the factors that might influence these events. Records of 961 individuals registered at two different family health centers in Istanbul were reviewed. Patients were contacted by phone, informed about the study, and data regarding their sociodemographic characteristics, medical histories, COVID-19 infection experiences, and medications used were collected. Comparative analyses (Fisher's exact test) and logistic regression tests were conducted.
Conditions
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2022-06-30
- Completion
- 2022-09-30
- First posted
- 2024-11-19
- Last updated
- 2024-11-19
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06695377. Inclusion in this directory is not an endorsement.